Cellular Entry of HIV: Evaluation of Therapeutic Targets

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|12|16|1963-1973

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.12, Iss.16, 2006-01, pp. : 1963-1973

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evaluation of Current Approaches to Inhibit HIV Entry

By  

Current Drug Targets - Infectious Disorders, Vol. 2, Iss. 1, 2002-03 ,pp. : 9-16

Bentham Science Publishers

Access to resources Recommend Favorite

Ubiquitin ligases as therapeutic targets in HIV-1 infection

By Votteler Jörg   Schubert Ulrich  

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 2, 2008-02 ,pp. : 131-143

Informa Healthcare

Access to resources Recommend Favorite

Stages of HIV Replication and Targets for Therapeutic Intervention

By  

Current Topics in Medicinal Chemistry, Vol. 3, Iss. 13, 2003-09 ,pp. : 1447-1457

Bentham Science Publishers

Access to resources Recommend Favorite

Dissecting HIV Fusion: Identifying Novel Targets for Entry Inhibitors

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 6, Iss. 4, 2006-12 ,pp. : 355-367

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic potential of blocking HIV entry into cells: focus on membrane fusion inhibitors

By Kilby J.M.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 8, 1999-08 ,pp. : 1157-1170

Informa Healthcare

Access to resources Recommend Favorite